SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-320821
Filing Date
2021-11-05
Accepted
2021-11-05 06:10:05
Documents
15
Period of Report
2021-11-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d233634d8k.htm   iXBRL 8-K 27720
2 EX-99.1 d233634dex991.htm EX-99.1 10918
3 EX-99.2 d233634dex992.htm EX-99.2 9239
7 GRAPHIC g233634snap1.jpg GRAPHIC 11990
  Complete submission text file 0001193125-21-320821.txt   197152

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cala-20211102.xsd EX-101.SCH 2895
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20211102_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20211102_pre.xml EX-101.PRE 11410
8 EXTRACTED XBRL INSTANCE DOCUMENT d233634d8k_htm.xml XML 3377
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 211382204
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences